Quest Diagnostics hits record high after upbeat 2026 forecast

Quest Diagnostics

10/02/2026 15:08

Updates

** Shares of laboratory operator Quest Diagnostics DGX.N rise 6.51% to an all-time high of $203.70

** Co forecasts 2026 revenue in the range of $11.7 billion to $11.82 billion, above analysts' estimates of $11.39 billion, according to data compiled by LSEG

** Forecasts 2026 adj. profit per share between $10.50 and $10.70, compared with estimates of $10.43

** Posts 7.1% increase in Q4 revenue to $2.81 billion, beating estimates of $2.75 billion

** Reports Q4 adj. profit per share of $2.42, vs. estimates of $2.36

** DGX stock rose 15% in 2025

(Reporting by Gnaneshwar Rajan in Bengaluru)

((Gnaneshwar.Rajan@thomsonreuters.com;))